AI Summary

Researchers at Weill Cornell Medicine have created a computer‑based virtual cell model designed to streamline the development of protein‑degrading therapies, a class of treatments gaining attention for cancer applications. The model simulates how targeted molecules interact with cellular proteins, allowing scientists to predict efficacy and optimize designs more efficiently. Findings describing the model were published on July 13 in Nature Communications.

AI summaries can be wrong sometimes—always verify important details using the source article.